Reminder: Clinical Trials for a medication/device that could be the first ever medication specifically designated for treating CVS. New sites have been added.
The CVSA and Alexza Pharmaceuticals would like to inform the CVSA membership of a clinical trial that has recently begun for adult patients with CVS.
The title of the study is: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STACCATO® GRANISETRON (AZ-010) FOR THE ACUTE TREATMENT OF MODERATE TO SEVERE CYCLIC VOMITING SYNDROME.